Combination I-O Treatment Factors & Preference
May 01, 2019 – 
Key opinion leaders discuss the immuno-combination treatment factors for patients with metastatic NSCLC.
Multiple Sclerosis: Managing Comorbidities
April 29, 2019 – 
The management of comorbidities is defined as an essential part of multiple sclerosis care.
Importance of Lifestyle Changes in MS
April 29, 2019 – 
Key opinion leaders break down multiple sclerosis–targeted lifestyle changes to aide patients in managing their disease.
Metastatic NSCLC I-O Combination Therapies
April 24, 2019 – 
A discussion on the available immuno-combination therapies for patients with metastatic non–small lung cancer, with special consideration to the CheckMate 227, IMpower150 and -131 studies.
NSCLC Treatment: Low PD-L1 Status and Chemotherapy
April 24, 2019 – 
Oncologists consider the management of patients with low PD-L1 status and the role of chemotherapy in treating patients with nondriver non–small cell lung cancer.
Understanding the Types of Multiple Sclerosis
April 22, 2019 – 
Given the heterogeneous nature of multiple sclerosis, experts break down the different subtypes and their impact on outlook.
Criteria for Diagnosing and Assessing MS
April 22, 2019 – 
Experts reflect on available criteria that aide in the appropriate diagnosis of multiple sclerosis.
Nondriver NSCLC Trials: KEYNOTE-189, -407, -024
April 17, 2019 – 
A discussion on the design, results, and practical implication of KEYNOTE-189, -407, and -024 trials.
Nondriver NSCLC Treatment Factors
April 17, 2019 – 
Expert physicians discuss the factors considered when choosing treatment for nondriver non–small cell lung cancer.
Multiple Sclerosis: Considering Symptoms and Diagnosis
April 15, 2019 – 
A comprehensive outline of symptoms tied to multiple sclerosis, as well as the proper pathway for diagnosis.
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.